Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

OMCL - Omnicell, Inc. So'nggi Yangiliklar | Finranks

Home

OMCL

O

Omnicell, Inc. (OMCL)

NMS – Real vaqt narxi. Valyuta: USD

32.75

-2.45 (-6.96%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

32.76

+0.01 (0.03%)

Bozordan keyin: Mar 27, 2026, 7:19 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Should You Continue to Hold OMCL Stock in Your Portfolio?

Should You Continue to Hold OMCL Stock in Your Portfolio?

Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.

Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript

Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript

Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript

Omnicell (OMCL) Q4 Earnings Lag Estimates

Omnicell (OMCL) Q4 Earnings Lag Estimates

Omnicell (OMCL) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.6 per share a year ago.

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results.

OMCL or HIMS: Which Is the Better Value Stock Right Now?

OMCL or HIMS: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?

Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline

Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes

3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes

Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.

Videolar

No Data

There is no data to display

Press-relizlar

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results.

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

08.12.2025

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

FORT WORTH, Texas--(BUSINESS WIRE)--Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management.

Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show

Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show.

Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies.